Isracann Bioscience Inc. (ISCNF)

[bell345]

Total Assets $ 53,164,104 Total liabilities 1,948,657

Pretty good


Weighted Average Number
of Shares Outstanding 73,924,390

2. BASIS OF PRESENTATION
a. Going Concern
Although the Company has invested resources into its business, the Company does not yet have any significant cash
flow from operations and as such, it must rely on equity financing to fund operations. To date, the Company’s main
source of funding has been the issuance of equity securities for cash through private placements. The Company has
historically raised operating capital from the sale of equity and will continue to do so.
The interim condensed consolidated financial statements have been prepared on the